» Articles » PMID: 27002337

Development and Evaluation of a Parallel Reaction Monitoring Strategy for Large-Scale Targeted Metabolomics Quantification

Overview
Journal Anal Chem
Specialty Chemistry
Date 2016 Mar 23
PMID 27002337
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in mass spectrometers which have yielded higher resolution and faster scanning speeds have expanded their application in metabolomics of diverse diseases. Using a quadrupole-Orbitrap LC-MS system, we developed an efficient large-scale quantitative method targeting 237 metabolites involved in various metabolic pathways using scheduled, parallel reaction monitoring (PRM). We assessed the dynamic range, linearity, reproducibility, and system suitability of the PRM assay by measuring concentration curves, biological samples, and clinical serum samples. The quantification performances of PRM and MS1-based assays in Q-Exactive were compared, and the MRM assay in QTRAP 6500 was also compared. The PRM assay monitoring 237 polar metabolites showed greater reproducibility and quantitative accuracy than MS1-based quantification and also showed greater flexibility in postacquisition assay refinement than the MRM assay in QTRAP 6500. We present a workflow for convenient PRM data processing using Skyline software which is free of charge. In this study we have established a reliable PRM methodology on a quadrupole-Orbitrap platform for evaluation of large-scale targeted metabolomics, which provides a new choice for basic and clinical metabolomics study.

Citing Articles

Advancements in Mass Spectrometry-Based Targeted Metabolomics and Lipidomics: Implications for Clinical Research.

Anh N, Thu N, Tien N, Long N, Nguyen H Molecules. 2025; 29(24.

PMID: 39770023 PMC: 11677340. DOI: 10.3390/molecules29245934.


Quantitative Monitoring of Cyclic Glycine-Proline in Marine Mangrove-Derived Fungal Metabolites.

Lin J, Qin F, Lin Z, Lin W, You M, Xu L J Fungi (Basel). 2024; 10(11).

PMID: 39590698 PMC: 11595644. DOI: 10.3390/jof10110779.


Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications.

Zhang F, Shan S, Fu C, Guo S, Liu C, Wang S Molecules. 2024; 29(11).

PMID: 38893405 PMC: 11173766. DOI: 10.3390/molecules29112530.


Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α.

Xia J, Chen H, Wang X, Chen W, Lin J, Xu F Nat Commun. 2024; 15(1):4755.

PMID: 38834568 PMC: 11150497. DOI: 10.1038/s41467-024-48954-2.


The "depict" strategy for discovering new compounds in complex matrices: Lycibarbarspermidines as a case.

Han C, Zhang Z, Feng Z, Zhai C, Li X, Shi Y J Pharm Anal. 2024; 14(3):416-426.

PMID: 38618244 PMC: 11010613. DOI: 10.1016/j.jpha.2023.10.007.